Hemorrhagic transformation of ischemic stroke: Prediction with CT perfusion

Radiology

Volumn 250, Issue 3, 2009, Pages 867-877

  Aviv, Richard I ^a   D'Esterre, Christopher D ^c   Murphy, Blake D ^c   Hopyan, Julia J ^a   Buck, Brian ^d   Mallia, Gabriella ^a   Li, Vivian ^a   Zhang, Liying ^b   Symons, Sean P ^a   Lee, Ting Yim ^c  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

^d GREY NUNS COMMUNITY HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IOHEXOL; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN HEMORRHAGE; BRAIN PERFUSION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; INFORMED CONSENT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PERMEABILITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

AGED; BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; FEMALE; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; PERFUSION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STROKE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 62649126254     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2503080257     Document Type: Article

References (52)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ische-mic stroke. N Engl J Med 1995;333:1581-1587.
2. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-1025.
3. Larrue V, von Kummer RR, Muller A, Bluhmki E. Risk factors for severe hemor-rhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 2001;32:438- 441.
4. Hacke W, Albers G, Al-Rawi Y, et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66-73.
5. Fisher M, Adams RD. Observations on brain embolism with special reference to the mechanism of hemorrhagic infarction. J Neuropathol Exp Neurol 1951;10:92-94.
6. Larrue V, von Kummer R, del Zoppo G, Bluhmki E. Hemorrhagic transformation in acute ischemic stroke: potential contributing factors in the European Cooperative Acute Stroke Study. Stroke 1997;28:957-960.
7. Tong DC, Adami A, Moseley ME, Marks MP. Relationship between apparent diffusion coefficient and subsequent hemorrhagic transformation following acute ischemic stroke. Stroke 2000;31:2378-2384.
8. Molina CA, Alvarez-Sabin J, Montaner J, et al. Thrombolysis-related hemorrhagic infarction: a marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion. Stroke 2002;33:1551-1556.
9. Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II): Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-1251.
10. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363:768-774.
11. Neumann-Haefelin T, Hoelig S, Berkefeld J, et al. Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke. Stroke 2006;37:2463-2466.
12. Kase CS, Furlan AJ, Wechsler LR, et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology 2001;57:1603-1610.
13. Berger C, Fiorelli M, Steiner T, et al. Hemor-rhagic transformationofischemic braintissue: asymptomatic or symptomatic? Stroke 2001;32:1330-1335.
14. Albers GW, Thijs VN, Wechsler L, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006;60:508-517.
15. von Kummer R. Brain hemorrhage after thrombolysis: good or bad? Stroke 2002;33:1446-1447.
16. Dzialowski I, Pexman JH, Barber PA, Demchuk AM, Buchan AM, HillMD. Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian Alteplase for Stroke Effectiveness Study registry. Stroke 2007;38:75-79.
17. Fiorelli M, Bastianello S, von Kummer R, et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke 1999;30:2280-2284.
18. Neumann-Haefelin C, Brinker G, Uhlenkuken U, Pillekamp F, Hossmann KA, Hoehn M. Prediction of hemorrhagic transformation after thrombolytic therapy ofclot embolism: an MRI investigation in rat brain. Stroke 2002;33:1392-1398.
19. Hamann GF, Okada Y, Fitridge R, del Zoppo GJ. Microvascular basal lamina antigens disappear during cerebral ischemia and reper-fusion. Stroke 1995;26:2120-2126.
20. Kassner A, Roberts T, Taylor K, Silver F, Mikulis D. Predictionofhemorrhage inacute ischemic stroke using permeability MR imaging. AJNR Am J Neuroradiol 2005;26:2213-2217.
21. Schaefer PW, Roccatagliata L, Ledezma C, et al. First-pass quantitative CT perfusion identifies thresholds for salvageable penumbra in acute stroke patients treated with in-tra-arterial therapy. AJNR Am J Neuroradiol 2006;27:20-25.
22. Wintermark M, Flanders AE, Velthuis B, et al. Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke 2006;37:979-985.
23. Murphy BD, Fox AJ, Lee DH, et al. Identifi-cation of penumbra and infarct in acute ische-mic stroke using computed tomography per-fusion-derived blood flow and blood volume measurements. Stroke 2006;37:1771-1777.
24. Murphy BD, Fox AJ, Lee DH, et al. White matter thresholds for ischemic penumbra and infarct core in patients with acute stroke: CT perfusion study. Radiology 2008;247:818-825.
25. Lee TY. Functional CT: physiological models. Trends Biotechnol 2002;20(suppl):S3-S10.
26. Cenic A, Nabavi DG, Craen RA, Gelb AW, Lee TY. A CT method to measure hemody-namics in brain tumors: validation and application of cerebral blood flow maps. AJNR Am J Neuroradiol 2000;21:462-470.
27. Purdie TG, Henderson E, Lee TY. Functional CT imaging of angiogenesis in rabbit VX2 soft-tissue tumour. Phys Med Biol 2001;46:3161-3175.
28. Roberts HC, Roberts TP, Lee TY, DillonWP. Dynamic, contrast-enhanced CT of human brain tumors: quantitative assessment of blood volume, blood flow, and microvascular permeability-report of two cases. AJNR Am J Neuroradiol 2002;23:828-832.
29. Lin K, Kazmi KS, Law M, Babb J, Peccerelli N, Pramanik BK. Measuring elevated micro-vascular permeability and predicting hemor-rhagic transformation in acute ischemic stroke using first-pass dynamic perfusion CT imaging. AJNR Am J Neuroradiol 2007;28:1292-1298.
30. Adams HP Jr, Adams RJ, Brott T, et al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003;34:1056-1083.
31. 31.Demchuk AM, Coutts SB. Alberta Stroke Program early CT score in acute stroke triage. Neuroimaging Clin N Am 2005;15:409-419, xii.
32. Lee TY, Stewart E. Scientific basis and validation. In: Miles KA, Cuenod CA, eds. Multidetector computed tomography in oncology: CT perfusion. London, England: Informa Healthcare, 2007; 15-46.
33. Johnson JA, Wilson TA. A model for capillary exchange. Am J Physiol 1966;210:1299-1303.
34. Murphy BD, Fox AJ, Lee DH, et al. White matter thresholds for ischemic penumbra and infarct core in patients with acute stroke: CT perfusion study. Radiology 2008;247:818-825.
35. Latour LL, Kang DW, Ezzeddine MA, Chalela JA, Warach S. Early blood-brain barrierdisruptioninhumanfocalbrainische-mia. Ann Neurol 2004;56:468-477.
36. Hjort N, Wu O, Ashkanian M, et al. MRI detection of early blood-brain barrier disruption: parenchymal enhancement predicts focal hem-orrhagic transformation after thrombolysis. Stroke 2008;39:1025-1028.
37. Kim EY, Kim SS, Na DG, Roh HG, Ryoo JW, Kim HK. Sulcal hyperintensity on fluid-attenuated inversion recovery imaging in acute ischemic stroke patients treated with intra-arterial thrombolysis: iodinated contrast media as its possible cause and the association with hemorrhagic transformation. J Comput Assist Tomogr 2005;29:264-269.
38. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ische-mic stroke. N Engl J Med 1995;333:1581-1588.
39. The NINDS t-PA Stroke Study Group. Intra-cerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 1997;28: 2109-2118.
40. IMS Study Investigators. Hemorrhage in the Interventional Management of Stroke Study. Stroke 2006;37:847-851.
41. Davis SM, Donnan GA, Parsons MW, et al. Effects of alteplase beyond 3 h after stroke inthe Echoplanar Imaging Thnombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trail. Lancet Neurol 2008;7(4):299-309.
42. Arnould MC, Grandin CB, Peeters A, Cosnard G, Duprez TP. Comparison of CT and three MR sequences for detecting and categorizing early (48 hours) hemorrhagic transformation in hyperacute ischemic stroke. AJNR Am J Neuroradiol 2004;25: 939-944.
43. Lin DD, Filippi CG, Steever AB, Zimmerman RD. Detection of intracranial hemorrhage: comparison between gradient-echo images and b(0) images obtained from diffusion-weighted echo-planar sequences. AJNR Am J Neuroradiol 2001;22:1275-1281.
44. Tan JC, Dillon WP, Liu S, Adler F, Smith WS, Wintermark M. Systematic comparison ofperfusion-CTand CT-angiography in acute stroke patients. Ann Neurol 2007;61:533-543.
45. Camargo EC, Furie KL, Singhal AB, et al. Acute brain infarct: detection and delineation with CT angiographic source images versus nonenhanced CT scans. Radiology 2007;244:541-548.
46. Aviv RI, Shelef I, Malam S, et al. Early stroke detection and extent: impact of experience and the role of computed tomography an-giography source images. Clin Radiol 2007;62:447-452.
47. Rother J, Schellinger PD, Gass A, et al. Effect of intravenous thrombolysis on MRI parameters and functional outcome in acutestroke <6 hours. Stroke 2002;33:2438-2445.
48. Lansberg MG, Thijs VN, Hamilton S, et al. Evaluation ofthe clinical-diffusion and perfu-sion-diffusion mismatch models in DEFUSE. Stroke 2007;38:1826-1830.
49. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ische-mic stroke: the PROACT II Study - a randomized controlled trial: prolyse in acute cerebral thromboembolism. JAMA 1999;282:2003-2011.
50. Ohta H, Nakano S, Yokogami K, Iseda T, Yoneyama T, Wakisaka S. Appearance of early venous filling during intraarterial reperfusion therapy for acute middle cerebral artery occlusion: a predictive sign for hemorrhagic complications. Stroke 2004;35: 893-898.
51. 51.Yoon W, Seo JJ, Kim JK, Cho KH, Park JG, Kang HK. Contrast enhancement and contrast extravasation on computed tomography after intra-arterial thrombolysis in patients with acute ischemic stroke. Stroke 2004;35:876- 881.
52. Hayman LA, Evans RA, Bastion FO, Hinck VC. Delayed high dose contrast CT: identifying patients at risk of massive hemor-rhagic infarction. AJR Am J Roentgenol 1981;136:1151-1159.